Noninvasive prenatal testing equipment, also known as noninvasive parenteral screening equipment, refers to the examination of the presence of fetal DNA in the mother's serum to detect the common fetal aneuploidy of the newborn genetic process.
This report contains market size and forecasts of Non-Invasive Prenatal Testing Devices in global, including the following market information:
Global Non-Invasive Prenatal Testing Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-Invasive Prenatal Testing Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-Invasive Prenatal Testing Devices companies in 2021 (%)
The global Non-Invasive Prenatal Testing Devices market was valued at 5025.8 million in 2021 and is projected to reach US$ 9932.2 million by 2028, at a CAGR of 10.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ultrasound Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Prenatal Testing Devices include Philips, Illumina, Thermo Fisher, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, QIAGEN, GE Healthcare and BGI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Prenatal Testing Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Prenatal Testing Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Prenatal Testing Devices Market Segment Percentages, by Type, 2021 (%)
Ultrasound Devices
Next-Generation Sequencing Systems
Polymerase Chain Reaction Instruments
Microarrays
Other
Global Non-Invasive Prenatal Testing Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Prenatal Testing Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Research Laboratories
Global Non-Invasive Prenatal Testing Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Prenatal Testing Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Prenatal Testing Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-Invasive Prenatal Testing Devices revenues share in global market, 2021 (%)
Key companies Non-Invasive Prenatal Testing Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-Invasive Prenatal Testing Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Philips
Illumina
Thermo Fisher
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
QIAGEN
GE Healthcare
BGI
HYK Gene
Roche
Berry Genomics
CapitalBio
LabCorp
LifeLabs Genetics
LifeCodexx
Natera
Quest Diagnostics
Sequenom
Genpharm Services